LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 67.10 | 771.67 | 5402 | 9800 | 0.5512 | 0.7001 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 67.10 | 771.67 | 5144 | 9800 | 0.5249 | 0.6776 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 69.32 | 771.67 | 5605 | 10212 | 0.5489 | 0.7026 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 69.32 | 771.67 | 5392 | 10212 | 0.5280 | 0.6850 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 71.54 | 771.67 | 5920 | 10532 | 0.5621 | 0.7166 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 71.54 | 771.67 | 5658 | 10532 | 0.5372 | 0.6961 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 73.76 | 771.67 | 6099 | 10851 | 0.5620 | 0.7196 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 73.76 | 771.67 | 5925 | 10851 | 0.5460 | 0.7066 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 76.02 | 771.67 | 6340 | 11106 | 0.5708 | 0.7288 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 76.02 | 771.67 | 6204 | 11106 | 0.5586 | 0.7191 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 78.25 | 771.67 | 6563 | 11367 | 0.5773 | 0.7360 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 78.25 | 771.67 | 6471 | 11367 | 0.5692 | 0.7297 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 80.48 | 771.67 | 6863 | 11685 | 0.5873 | 0.7461 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 80.48 | 771.67 | 6709 | 11685 | 0.5742 | 0.7361 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 82.69 | 771.67 | 6999 | 11974 | 0.5845 | 0.7461 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 82.69 | 771.67 | 6953 | 11974 | 0.5807 | 0.7432 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 84.92 | 771.67 | 7129 | 12266 | 0.5812 | 0.7457 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 84.92 | 771.67 | 7167 | 12266 | 0.5843 | 0.7480 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 87.14 | 771.67 | 7381 | 12592 | 0.5861 | 0.7516 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 87.14 | 771.67 | 7419 | 12592 | 0.5892 | 0.7539 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 2.49 | 771.67 | 721 | 867 | 0.8309 | -0.3305 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 2.49 | 771.67 | 805 | 867 | 0.9277 | 0.2837 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 2.49 | 771.67 | 878 | 867 | 1.0118 | 1.1436 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 4.71 | 771.67 | 841 | 956 | 0.8794 | 0.3204 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 4.71 | 771.67 | 899 | 956 | 0.9400 | 0.6377 | MN20160304_L01 | H12 |